BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 9115588)

  • 1. Altered glucocorticoid receptor expression and function during mouse skin carcinogenesis.
    Budunova IV; Carbajal S; Kang H; Viaje A; Slaga TJ
    Mol Carcinog; 1997 Mar; 18(3):177-85. PubMed ID: 9115588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of transformed mouse keratinocytes to growth inhibition by glucocorticoids.
    Spiegelman VS; Budunova IV; Carbajal S; Slaga TJ
    Mol Carcinog; 1997 Sep; 20(1):99-107. PubMed ID: 9328440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of phosphodiesterase antagonists on glucocorticoid mediated growth inhibition in murine skin cell lines.
    Kowalczyk P; Kinjo T; Kowalczyk M; Walaszek Z; Hanausek M; Slaga TJ
    Eur J Pharmacol; 2009 May; 610(1-3):29-36. PubMed ID: 19306867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desipramine inhibits the growth of a mouse skin squamous cell carcinoma cell line and affects glucocorticoid receptor-mediated transcription.
    Kinjo T; Kowalczyk P; Kowalczyk M; Walaszek Z; Nishimaki T; Slaga TJ; Hanausek M
    Mol Carcinog; 2009 Dec; 48(12):1123-30. PubMed ID: 19575421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid receptor functions as a potent suppressor of mouse skin carcinogenesis.
    Budunova IV; Kowalczyk D; Pérez P; Yao YJ; Jorcano JL; Slaga TJ
    Oncogene; 2003 May; 22(21):3279-87. PubMed ID: 12761498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol.
    Kiguchi K; Beltrán L; Rupp T; DiGiovanni J
    Mol Carcinog; 1998 Jun; 22(2):73-83. PubMed ID: 9655251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin.
    Rho O; Bol DK; You J; Beltrán L; Rupp T; DiGiovanni J
    Mol Carcinog; 1996 Oct; 17(2):62-9. PubMed ID: 8890954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
    La E; Muga SJ; Locniskar MF; Fischer SM
    Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
    Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
    Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
    Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
    Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.
    Allen SM; Florell SR; Hanks AN; Alexander A; Diedrich MJ; Altieri DC; Grossman D
    Cancer Res; 2003 Feb; 63(3):567-72. PubMed ID: 12566297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased skin carcinogenesis in a keratinocyte directed thioredoxin-1 transgenic mouse.
    Mustacich D; Wagner A; Williams R; Bair W; Barbercheck L; Stratton SP; Bhattacharyya AK; Powis G
    Carcinogenesis; 2004 Oct; 25(10):1983-9. PubMed ID: 15166090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papilloma development is delayed in osteopontin-null mice: implicating an antiapoptosis role for osteopontin.
    Hsieh YH; Juliana MM; Hicks PH; Feng G; Elmets C; Liaw L; Chang PL
    Cancer Res; 2006 Jul; 66(14):7119-27. PubMed ID: 16849558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen.
    Binder RL; Johnson GR; Gallagher PM; Stockman SL; Sundberg JP; Conti CJ
    Cancer Res; 1998 Oct; 58(19):4314-23. PubMed ID: 9766659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low iron diet retards 12-O-tetradecanoyl phorbol-13-acetate-mediated tumor promotion in murine skin.
    Bhasin G; Kauser H; Athar M
    Arch Toxicol; 2004 May; 78(5):283-9. PubMed ID: 14997284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary grape seed proanthocyanidins inhibit 12-O-tetradecanoyl phorbol-13-acetate-caused skin tumor promotion in 7,12-dimethylbenz[a]anthracene-initiated mouse skin, which is associated with the inhibition of inflammatory responses.
    Meeran SM; Vaid M; Punathil T; Katiyar SK
    Carcinogenesis; 2009 Mar; 30(3):520-8. PubMed ID: 19158151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion.
    Owens DM; Watt FM
    Cancer Res; 2001 Jul; 61(13):5248-54. PubMed ID: 11431366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connexin expression in epidermal cell lines from SENCAR mouse skin tumors.
    Budunova IV; Carbajal S; Viaje A; Slaga TJ
    Mol Carcinog; 1996 Mar; 15(3):190-201. PubMed ID: 8597532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene.
    Scribner JD; Scribner NK; McKnight B; Mottet NK
    Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice.
    Kruszewski FH; Conti CJ; DiGiovanni J
    Cancer Res; 1987 Jul; 47(14):3783-90. PubMed ID: 3109733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.